Amrutanjan Health Care Ltd

Amrutanjan Healt Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Amrutanjan Health Care Ltd

₹ 700 -0.81%
22 Nov - close price
amrutanjan.com BSE: 590006 NSE: AMRUTANJAN
About

AHCL has been manufacturing ayurvedic balm for pain management since 1893, and is currently managed by the third-generation of promoters. The company is more than 120 years old and is into OTC products in the segments of pain management, women's hygiene, and packaged fruit juice drink. [1]

Key Points

High Market Share in Modern Trade
Amrutanjan has maintained the No. 1 rank in Modern Trade in Head Category with the volume market share of 41.1%* in CY19. [1]

Website BSE NSE
  • Market Cap ₹ 2,023 Cr.
  • Current Price ₹ 700
  • High / Low ₹ 863 / 556
  • Stock P/E 99.3
  • Book Value ₹ 37.2
  • Dividend Yield 0.66 %
  • ROCE 31.4 %
  • ROE 20.0 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 33.0%

Cons

  • Stock is trading at 18.8 times its book value
  • Promoter holding has decreased over last quarter: -4.07%
  • The company has delivered a poor sales growth of 11.8% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Operating Profit
OPM %
Interest
Depreciation
Profit before tax
Tax %
EPS in Rs
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016
67 69 71 87 86 101 136 131 134 158 177
53 53 60 182 76 88 118 113 112 134 145
Operating Profit 13 16 11 -95 10 13 18 17 22 24 31
OPM % 20% 23% 16% -109% 12% 13% 13% 13% 16% 15% 18%
1 -2 0 220 10 5 4 4 3 4 5
Interest 1 1 1 0 0 1 3 2 2 1 0
Depreciation 3 2 2 2 1 2 3 4 4 3 3
Profit before tax 11 11 9 123 19 15 16 15 19 24 33
Tax % 45% 46% 42% 25% 38% 34% 39% 35% 36% 38% 37%
6 6 5 92 11 10 10 10 12 15 21
EPS in Rs 29.80 3.32 3.47 4.26 5.10 7.05
Dividend Payout % 22% 32% 45% 19% 40% 45% 45% 43% 38% 34% 27%
Compounded Sales Growth
10 Years: 10%
5 Years: 12%
3 Years: 11%
TTM: 12%
Compounded Profit Growth
10 Years: 13%
5 Years: 15%
3 Years: 27%
TTM: 37%
Stock Price CAGR
10 Years: 12%
5 Years: 9%
3 Years: -8%
1 Year: 14%
Return on Equity
10 Years: 15%
5 Years: 15%
3 Years: 17%
Last Year: 20%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016
Equity Capital 3 3 3 3 3 3 3 3 3 3 3
Reserves 15 20 23 90 94 98 74 79 86 92 106
6 8 8 1 1 30 22 15 8 2 2
13 10 14 17 20 26 25 27 23 26 29
Total Liabilities 37 41 48 111 118 157 124 124 120 124 140
16 13 20 16 16 52 33 30 27 24 29
CWIP 0 3 3 2 7 0 1 1 1 4 1
Investments 0 0 0 0 46 42 29 25 9 9 9
21 26 25 92 50 62 62 69 83 87 102
Total Assets 37 41 48 111 118 157 124 124 120 124 140

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016
10 11 5 6 11 6 4 9 17 18 21
3 -4 -8 89 -47 -29 14 13 16 -5 4
-12 -1 -2 -30 -8 20 -27 -14 -14 -12 -13
Net Cash Flow 1 6 -5 65 -43 -4 -9 8 20 1 12

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016
Debtor Days 42 26 40 54 43 43 47 79 68 64 57
Inventory Days 93 121 117 52 84 87 74 66 56 50 49
Days Payable 80 76 76 69 122 90 76 56 44 45 51
Cash Conversion Cycle 55 71 81 37 5 40 45 88 80 69 55
Working Capital Days 48 52 67 44 36 42 51 71 65 50 55
ROCE % 54% 29% 28% 18% 14% 16% 18% 23% 26% 31%

Shareholding Pattern

Numbers in percentages

7 Recently
Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
50.02% 50.02% 50.02% 50.02% 50.02% 50.03% 50.03% 50.59% 50.59% 50.59% 50.58% 46.52%
1.83% 1.43% 1.42% 0.87% 0.76% 0.68% 0.69% 0.75% 0.80% 1.38% 1.55% 2.34%
6.14% 6.14% 6.16% 6.30% 6.39% 7.18% 7.22% 7.10% 7.24% 7.29% 7.32% 10.60%
41.90% 42.23% 42.21% 42.62% 42.65% 41.93% 41.87% 41.39% 41.19% 40.66% 40.47% 40.50%
0.11% 0.18% 0.18% 0.18% 0.18% 0.18% 0.18% 0.18% 0.18% 0.07% 0.07% 0.04%
No. of Shareholders 61,36767,32366,17371,06472,10469,94771,42872,00268,40462,66457,16954,536

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls

  • Nov 2024
    Transcript
    Notes
    PPT
  • Aug 2024
    Transcript
    Notes
    PPT
  • May 2024
    Transcript
    Notes
    PPT
  • Feb 2024
    Transcript
    Notes
    PPT
  • Nov 2023
    Transcript
    Notes
    PPT
  • Aug 2023
    Transcript
    Notes
    PPT
  • Jun 2023
    Transcript
    Notes
    PPT
  • Feb 2023
    Transcript
    Notes
    PPT
  • Nov 2022
    Transcript
    Notes
    PPT
  • Aug 2022
    Transcript
    Notes
    PPT
  • May 2022
    Transcript
    Notes
    PPT
  • Feb 2022
    Transcript
    Notes
    PPT
  • Nov 2021
    Transcript
    Notes
    PPT
  • Aug 2021
    Transcript
    Notes
    PPT
  • May 2021
    Transcript
    Notes
    PPT
  • Feb 2021
    Transcript
    Notes
    PPT
  • Nov 2020
    Transcript
    Notes
    PPT
  • Aug 2020
    Transcript
    Notes
    PPT
  • Jun 2020
    Transcript
    Notes
    PPT
  • Feb 2020
    Transcript
    Notes
    PPT
  • Feb 2020
    Transcript
    Notes
    PPT
  • Nov 2019
    Transcript
    Notes
    PPT
  • Aug 2019
    Transcript
    Notes
    PPT
  • May 2019
    Transcript
    Notes
    PPT